Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yang-liang Ye
OL3, a Novel Low-Absorbed TGR5 Agonist With Reduced Side Effects, Lowered Blood Glucose via Dual Actions on TGR5 Activation and DPP-4 Inhibition
Acta Pharmacologica Sinica
Medicine
Pharmacology
Related publications
Effects of Chemical Modification of Ursodeoxycholic Acid on TGR5 Activation
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Activation of TGR5 Partially Alleviates High Glucose-Induced Cardiomyocyte Injury by Inhibition of Inflammatory Responses and Oxidative Stress
Oxidative Medicine and Cellular Longevity
Biochemistry
Medicine
Cell Biology
Aging
TGR5 Activation Promotes Stimulus-Secretion Coupling of Pancreatic Beta-Cells via a PKA-Dependent Pathway
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet Α Cells to Promote Glucose Homeostasis
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
TGR5 Activation Ameliorates Hyperglycemia-Induced Cardiac Hypertrophy in H9c2 Cells
Scientific Reports
Multidisciplinary
Ginsenoside Rg1, a Novel Glucocorticoid Receptor Agonist of Plant Origin, Maintains Glucocorticoid Efficacy With Reduced Side Effects
Journal of Immunology
Allergy
Immunology
DPP-4 Inhibition and Neuroprotection: Do Mechanisms Matter?
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Erratum To: DPP-4 Inhibitors in Diabetic Complications: Role of DPP-4 Beyond Glucose Control
Archives of Pharmacal Research
Organic Chemistry
Drug Discovery
Molecular Medicine
Combination of PPAR-α Agonist and DPP-4 Inhibitor: A Novel Therapeutic Approach in the Management of Diabetic Nephropathy
Journal of Diabetes & Metabolism